¹Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD, USA.
²Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD, USA.
³Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
⁴Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
⁵Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
⁶Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
⁷Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
⁸Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
⁹Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
¹⁰Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹¹Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
¹²Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹³Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁴Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
¹⁵Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
¹⁶Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
¹⁷Department of Epidemiology, Genetic Epidemiology Research Institute, University of California, Irvine, Irvine, CA, USA.
¹⁸Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
¹⁹Department of Public Health Sciences and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.
²⁰Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
²¹Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
²²Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
²³Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
²⁴Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
²⁵Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
²⁶Division of Cancer Epidemiology, DKFZ, Heidelberg, Germany.
²⁷Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Valencia, Spain.
²⁸Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
²⁹Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
³⁰Molecular Medicine Unit, Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.
³¹Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
³²N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
³³Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
³⁴Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, Milan, Italy.
³⁵Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, Milan, Italy.
³⁶Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden.
³⁷Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
³⁸Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
³⁹Bioscience Department, Faculty of Medicine, Universidad de la Sabana, Chia, Colombia.
⁴⁰Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
⁴¹Department of Women's Health, University of Tübingen, Tübingen, Germany.
⁴²Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Ruhr University Bochum, Bochum, Germany.
⁴³Molecular Epidemiology Group (C080), DKFZ, Heidelberg, Germany.
⁴⁴Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT, USA.
⁴⁵Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester NIHR Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
⁴⁶Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
⁴⁷Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy.
⁴⁸Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, Milan, Italy.
⁴⁹Division of Cancer Epidemiology, DKFZ, Heidelberg, Germany.
⁵⁰Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
⁵¹Division of Cancer Epidemiology, DKFZ, Heidelberg, Germany.
⁵²Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD, USA.
⁵³Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
⁵⁴Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
⁵⁵Departments of Pediatrics and Medicine, Columbia University, New York, NY, USA.
⁵⁶Centre for Medical Genetics, Ghent University, Ghent, Belgium.
⁵⁷Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
⁵⁸Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
⁵⁹Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
⁶⁰Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
⁶¹Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK.
⁶²Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁶³Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
⁶⁴Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
⁶⁵Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
⁶⁶Department of Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
⁶⁷Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
⁶⁸Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK.
⁶⁹Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
⁷⁰Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center ER-EMN, Erlangen, Germany.
⁷¹Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester NIHR Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
⁷²Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
⁷³Usher Institute of Population Health Sciences and Informatics, University of Edinburgh Medical School, Edinburgh, UK.
⁷⁴Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
⁷⁵Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece.
⁷⁶The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.
⁷⁷Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
⁷⁸Genomic Medicine Group, Galician Foundation of Genomic Medicine, IDIS, Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
⁷⁹Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA.
⁸⁰Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA, USA.
⁸¹Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
⁸²Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA.
⁸³Center for Bioinformatics and Functional Genomics and the Cedars-Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
⁸⁴Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
⁸⁵Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, KS, USA.
⁸⁶Department of Medicine, McGill University, Montréal, Québec, Canada.
⁸⁷Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
⁸⁸Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
⁸⁹Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
⁹⁰Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
⁹¹Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University of Paris-Saclay, Paris, France.
⁹²Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center ER-EMN, Erlangen, Germany.
⁹³Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
⁹⁴Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
⁹⁵Waukesha Memorial Hospital Pro Health Care, Waukesha, WI, USA.
⁹⁶Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
⁹⁷Molecular Genetics of Breast Cancer, DKFZ, Heidelberg, Germany.
⁹⁸Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
⁹⁹Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
¹⁰⁰Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
¹⁰¹Family Cancer Clinic, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
¹⁰²Saarland Cancer Registry, Saarbrücken, Germany.
¹⁰³Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
¹⁰⁴Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
¹⁰⁵Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD, USA.
¹⁰⁶Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
¹⁰⁷Division of Cancer Sciences, University of Manchester, Manchester, UK.
¹⁰⁸Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
¹⁰⁹Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA.
¹¹⁰N.N. Petrov Institute of Oncology, St. Petersburg, Russia.
¹¹¹Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
¹¹²Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
¹¹³Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
¹¹⁴Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, Skopje, Republic of Macedonia.
¹¹⁵Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
¹¹⁶Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
¹¹⁷Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania.
¹¹⁸Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
¹¹⁹Department of Medicine, Division of Oncology, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, CA, USA.
¹²⁰Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
¹²¹Division of Cancer Epidemiology, DKFZ, Heidelberg, Germany.
¹²²Division of Cancer Epidemiology, DKFZ, Heidelberg, Germany.
¹²³Division of Cancer Epidemiology, DKFZ, Heidelberg, Germany.
¹²⁴David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California, Los Angeles, Los Angeles, CA, USA.
¹²⁵Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
¹²⁶Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
¹²⁷Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
¹²⁸Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
¹²⁹Department of Internal Medicine, Evangelische Kliniken Bonn, Johanniter Krankenhaus, Bonn, Germany.
¹³⁰Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece.
¹³¹Department of Surgical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
¹³²Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD, USA.
¹³³Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
¹³⁴Department of Surgical Pathology, Zealand University Hospital, Slagelse, Denmark.
¹³⁵VIB Center for Cancer Biology, VIB, Leuven, Belgium.
¹³⁶Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
¹³⁷Université Paris Sorbonne Cité, INSERM UMR-S1147, Paris, France.
¹³⁸Molecular Diagnostic Unit, Hereditary Cancer Program, Bellvitge Biomedical Research Institute (IDIBELL), Catalan Institute of Oncology (ICO), CIBERONC, Barcelona, Spain.
¹³⁹Ss. Cyril and Methodius University in Skopje, Medical Faculty, University Clinic of Radiotherapy and Oncology, Skopje, Republic of North Macedonia.
¹⁴⁰Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
¹⁴¹Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁴²Genetic Epidemiology of Cancer Team, INSERM U900, Paris, France.
¹⁴³Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
¹⁴⁴Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Cancer Center, Oncology Institute, Warsaw, Poland.
¹⁴⁵Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
¹⁴⁶Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
¹⁴⁷Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
¹⁴⁸Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
¹⁴⁹Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
¹⁵⁰Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
¹⁵¹Molecular Genetics of Breast Cancer, DKFZ, Heidelberg, Germany.
¹⁵²Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
¹⁵³Department of Oncology, Södersjukhuset, Stockholm, Sweden.
¹⁵⁴Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
¹⁵⁵Immunology and Molecular Oncology Unit, Veneto Institute of Oncology (IOV)-IRCCS, Padua, Italy.
¹⁵⁶Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁵⁷Department of Anatomical Pathology, The Alfred Hospital, Melbourne, Victoria, Australia.
¹⁵⁸Genetic Epidemiology of Cancer Team, INSERM U900, Institut Curie, PSL University, Mines ParisTech, Paris, France.
¹⁵⁹Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany.
¹⁶⁰MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
¹⁶¹NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA.
¹⁶²Department of Genetics and Fundamental Medicine, Bashkir State Medical University, Ufa, Russia.
¹⁶³Immunology and Molecular Oncology Unit, Veneto Institute of Oncology (IOV)-IRCCS, Padua, Italy.
¹⁶⁴Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
¹⁶⁵Université Paris Sorbonne Cité, INSERM UMR-S1147, Paris, France.
¹⁶⁶Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
¹⁶⁷Department of Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
¹⁶⁸Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
¹⁶⁹Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
¹⁷⁰Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
¹⁷¹Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester NIHR Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
¹⁷²Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
¹⁷³Latvian Biomedical Research and Study Centre, Riga, Latvia.
¹⁷⁴Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
¹⁷⁵Clinical Genetics Research Laboratory, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁷⁶Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
¹⁷⁷Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA.
¹⁷⁸Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
¹⁷⁹Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK.
¹⁸⁰Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy.
¹⁸¹Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
¹⁸²Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
¹⁸³Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
¹⁸⁴Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
¹⁸⁵Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
¹⁸⁶Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
¹⁸⁷Genome Diagnostics Program, IFOM, FIRC Institute of Molecular Oncology, Milan, Italy.
¹⁸⁸Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
¹⁸⁹Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
¹⁹⁰NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA.
¹⁹¹Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, Skopje, Republic of Macedonia.
¹⁹²Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
¹⁹³Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
¹⁹⁴Department of Genetics and Fundamental Medicine, Bashkir State Medical University, Ufa, Russia.
¹⁹⁵Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
¹⁹⁶Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, INT, Milan, Italy.
¹⁹⁷Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia.
¹⁹⁸Clinical Genetics, Karolinska Institutet, Stockholm, Sweden.
¹⁹⁹Molecular Genetics of Breast Cancer, DKFZ, Heidelberg, Germany.
²⁰⁰Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
²⁰¹Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
²⁰²Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
²⁰³Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
²⁰⁴Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
²⁰⁵Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center ER-EMN, Erlangen, Germany.
²⁰⁶Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany.
²⁰⁷Department of Oncology, University Hospital of Larissa, Larissa, Greece.
²⁰⁸Prevent Breast Cancer Centre and Nightingale Breast Screening Centre, Manchester University NHS Foundation Trust, Manchester, UK.
²⁰⁹Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Durham, NC, USA.
²¹⁰Research Oncology, Guy's Hospital, King's College London, London, UK.
²¹¹Cancer Genetics and Prevention Program, University of California, San Francisco, San Francisco, CA, USA.
²¹²Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
²¹³Molecular Biology of Breast Cancer, University Women's Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.
²¹⁴Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
²¹⁵Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
²¹⁶Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
²¹⁷Clinical Cancer Genetics Program, Division of Human Genetics, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
²¹⁸Department of Internal Medicine, Division of Oncology, University of Kansas Medical Center, Westwood, Kansas City, KS, USA.
²¹⁹Department of Health Sciences Research, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
²²⁰Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
²²¹Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
²²²Ss. Cyril and Methodius University in Skopje, Medical Faculty, University Clinic of Radiotherapy and Oncology, Skopje, Republic of North Macedonia.
²²³Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, Québec, Canada.
²²⁴Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.
²²⁵Population Oncology, BC Cancer, Vancouver, British Columbia, Canada.
²²⁶Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
²²⁷Department of Genetics, INSERM U830, Institut Curie, Paris Descartes Sorbonne-Paris Cité University, Paris, France.
²²⁸Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
²²⁹National Human Genome Research Institute, National Cancer Institute, Bethesda, MD, USA.
²³⁰Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
²³¹Faculty of Medicine, University of Southampton, Southampton, UK.
²³²Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Durham, NC, USA.
²³³Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
²³⁴Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
²³⁵Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
²³⁶Department of Medicine, Magee-Womens Hospital, School of Medicine, University of Pittsburgh , Pittsburgh, PA, USA.
²³⁷Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Québec, Canada.
²³⁸Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
²³⁹Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
²⁴⁰Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
²⁴¹Molecular Genetics of Breast Cancer, DKFZ, Heidelberg, Germany.
²⁴²Department of Epidemiology, Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
²⁴³Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University of Paris-Saclay, Paris, France.
²⁴⁴Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
²⁴⁵Department of Gynecology and Obstetrics, Helios Clinics Berlin-Buch, Berlin, Germany.
²⁴⁶Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
²⁴⁷Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.
²⁴⁸Family Cancer Clinic, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
²⁴⁹Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester NIHR Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
²⁵⁰Department of Genetics, University of Pretoria, Pretoria, South Africa.
²⁵¹Molecular Medicine Unit, Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.
²⁵²Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
²⁵³Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, Durham, NC, USA.
²⁵⁴Clinical Cancer Genomics, City of Hope, Duarte, CA, USA.
²⁵⁵Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
²⁵⁶Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.
²⁵⁷Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
²⁵⁸Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD, USA.
²⁵⁹Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece.
²⁶⁰Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
²⁶¹Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
²⁶²Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
²⁶³Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
²⁶⁴Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, Québec, Canada.
²⁶⁵Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
²⁶⁶Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
²⁶⁷Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
²⁶⁸Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
²⁶⁹Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
²⁷⁰Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
²⁷¹Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. nchatte2@jhu.edu.
²⁷²Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD, USA.